Endocrinology
Feature
Can a tool help overcome barriers to diabetes medication cost?
Tool is designed to be a ‘broad conversation starter’ and not just about medications.
Latest News
Phthalate exposure via maternal and cord blood affects infant outcomes
Prenatal exposure to phthalates was inversely associated with head circumference in male and female infants.
Commentary
Growth hormone therapy for certain children may help them reach their potential
When should parents consider growth hormone therapy? In what cases is it warranted for children? Dr. Jessica Sparks Lilley discusses the need for...
Latest News
Growth in early life may predict early puberty
Children with rapid early growth may need monitoring for support services in the event of early puberty.
News
Endocrine Society and others to FDA: Restrict BPA
A petition requests that prior approvals of bisphenol A, a chemical contained in food packaging be removed, citing recent evidence of harm.
Feature
‘We just have to keep them alive’: Transitioning youth with type 1 diabetes
Transitioning a teen with type 1 diabetes from pediatric care to taking full responsibility for their own condition under an adult team is one of...
Latest News
Preschool boys’ behaviors traced back to moms’ thyroid hormones
Changes in maternal thyroid hormone levels during pregnancy may predict whether male offspring are aggressive or withdrawn preschoolers.
News
COVID-19 linked to increased diabetes risk in youth
Two large databases indicate significantly increased diabetes risk among those with COVID-19 but not other acute respiratory illnesses.
From the Journals
Does vitamin D benefit only those who are deficient?
The results will “allow clinicians to better weigh the potential benefits of supplementation against its risk,” such as financial cost.
From the Journals
Contact allergens in medical devices: A cause for concern?
Despite the clinical value of medical devices, there is a potential for these products to cause adverse skin reactions in some patients.
Feature
Hormone blocker sticker shock – again – as patients lose cheaper drug option
A company with two nearly identical drug products charged nearly eight times more for one of them.